PFS
JAZZ icon

Prospera Financial Services’s Jazz Pharmaceuticals JAZZ Stock Holding History

Prospera Financial Services’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,122
Closed -$261K – 1118
2023
Q4 		$261K Buy
2,122
+13
+0.6% +$1.62K 0.01% 904
2023
Q3 		$273K Sell
2,109
-19
-0.9% -$2.53K 0.01% 840
2023
Q2 		$264K Buy
+2,128
New +$286K 0.01% 855
2022
Q3 		– Sell
-7,521
Closed -$1.17M – 1230
2022
Q2 		$1.17M Sell
7,521
-544
-7% -$83.7K 0.06% 332
2022
Q1 		$1.25M Buy
+8,065
New +$1.17M 0.05% 375

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Prospera Financial Services's JAZZ Position: Q1 2024 in Review

Prospera Financial Services sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2024, closing a stake of 2,122 shares — an estimated $261K sold.

Prospera Financial Services first reported a position in JAZZ in Q1 2022 and held it in 5 quarters. The position peaked at $1.25M in Q1 2022. 481 funds tracked by Wall St. Rank hold JAZZ as of Q1 2024.

  • Prospera Financial Services reported no remaining Jazz Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Prospera Financial Services sold 2,122 Jazz Pharmaceuticals shares in Q1 2024, an estimated $261K.
  • Prospera Financial Services first reported a position in Jazz Pharmaceuticals in Q1 2022 and held it in 5 quarters.
  • Prospera Financial Services's Jazz Pharmaceuticals position peaked at $1.25M in Q1 2022.
  • 481 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2024.

Based on Prospera Financial Services's 13F filing for Q1 2024, filed 13 Aug 2024.